Pharmacoepidemiology and Risk Management

Real-World Evidence

Let us help you ensure the safety of your patients by examining and understanding disease indicators and using real-world evidence to support your development and post-approval activities.

To understand disease distribution, risk factors, treatment patterns and impact, comorbidities, burden-of-illness, other related factors, and the effectiveness of risk minimization interventions, our international and expert team of epidemiologists can help you ask the right questions and apply the right methodologies to yield meaningful and actionable evidence.

Whether you’re looking for consulting advice; database or registry study; prospective observational research; a literature review; or a risk management plan, we can provide you with high-quality, scientifically-rigorous, and publication-ready epidemiology support.

Rely On Our Experts

Resources from our experts:
Co-edited by Elizabeth AndrewsMann's Pharmacovigilance provides a definitive drug safety resource for pharmaceutical researchers and students. Learn more.
Authored by Kenneth RothmanEpidemiology: An Introduction, remains one of the most quoted epidemiology methods books since the late 1990s.

Our broad range of experience and relationships make us an ideal research partner for pharmacoepidemiology studies. Members of our 30+ person team of epidemiologists are often invited as advisors on steering and advisory committees convened by clients, research partners, governments, and academic organizations. We were selected by the European Medicines Agency (EMA) as a preferred provider to conduct post-authorization efficacy and safety studies—including pregnancy and breastfeeding research—to support regulatory decision-making.

Some of Our Consultative Roles and Experience:

Through our Barcelona based team, we are a partner center of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We have participated in over 45 studies registered in the EU PAS Register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

And with our membership in the VAC4EU, the Vaccine Monitoring Collaboration for Europe study network, we are helping to increase the availability of real-world evidence on vaccine coverage, benefits, and risks in Europe to support public health and decision making.

Collaborative Research Partners

We have extensive experience working with multiple research partners across Europe and North America to carry out multidatabase pharmacoepidemiology research studies. Collaborative research partners include:

    • Saskatchewan Health
    • Aarhus University
    • Southern Denmark University
    • Bordeaux University
    • BIPS (GePaRD)
    • German Institute of Medical Documentation and Information (DIMDI)
    • Oldenburg University
    • University of Cologne
    • Udine University
    • University of Milano Bicocca (UNIMIB)
    • Erasmus University
    • PHARMO Institute
    • Aragon Institute of Public Health
    • CEIFE
    • IDIAP Jordi Gol
    • Karolinska Institute
    • CPRD
    • Dundee University
    • Health Core
    • Kaiser Permanente Northern California
    • Kaiser Permanente Southern California
    • Kaiser Permanente Washington
    • Optum
    • Regenstrief Institute


Recent Publications